<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study aimed to investigate the maternal, pre- and perinatal, and prothrombotic factors with congenital <z:hpo ids='HP_0001269'>hemiparesis</z:hpo> due to presumed perinatal <z:hpo ids='HP_0001297'>stroke</z:hpo> (PPS) </plain></SENT>
<SENT sid="1" pm="."><plain>Prothrombotic risk factors including protein C and S, antithrombin III, <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> (a), homocystein, factor VIII levels; anticardiolipin antibodies and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>; <z:chebi fb="0" ids="25297">methylenetetrahydrofolate</z:chebi> reductase mutations, factor V Leiden, prothrombin G20210A mutations were investigated </plain></SENT>
<SENT sid="2" pm="."><plain>Arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> was detected in 60% and periventricular venous infarction in 40% </plain></SENT>
<SENT sid="3" pm="."><plain>At least one prothrombotic risk factor was present in 69%, two in 17%, and three or more in 8.5% of cases </plain></SENT>
<SENT sid="4" pm="."><plain>The most common combination was <z:chebi fb="0" ids="25297">methylenetetrahydrofolate</z:chebi> reductase C677T and factor V Leiden heterozygosity </plain></SENT>
<SENT sid="5" pm="."><plain>The etiology and pathogenesis of PPS is still unclear </plain></SENT>
<SENT sid="6" pm="."><plain>According to this study, most of the patients with PPS might have one or more prothrombotic risk factors and certain prenatal risk factors including <z:hpo ids='HP_0001511'>intrauterine growth retardation</z:hpo>, twin gestation and <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> might be related to PPS </plain></SENT>
</text></document>